by Steven Ertelt
June 3, 2007
Washington, DC (LifeNews.com) — When members of Congress return to Capitol Hill this week from their Memorial Day recess, they will renew their battle over a controversial bill that would make taxpayers fund embryonic stem cell research. Pro-Life groups are working overtime to keep the vote on the bill under the two-thirds needed to override a veto.
The House and Senate have already approve their respective versions of the bill and the House will vote on the Senate measure, S. 5, this week.
While the bill will undoubtedly pass, backers likely won’t be able to get the two-thirds vote necessary to overturn a veto President Bush has already promised. In an effort to preemptively rebuke the President’s veto, Speaker Nancy Pelosi is using the vote as a public relations stunt to showcase Congress’s approval for the research.
An expected veto is good news to pro-life groups, that know taxpayers will likely be protected from being forced to pay for the destruction of human life for scientific research at least until after the 2008 presidential elections.
National Right to Life legislative director Douglas Johnson told LifeNews.com he expects the House to vote on the embryonic funding bill on Thursday. He said he believed the president will veto the bill and that the Senate, and possible the House, will take up an override vote later in the month.
"Please call the offices of your federal representatives today to register your opposition to S. 5," Johnson urged pro-life advocates to do in the next couple of days.
Meanwhile, Family Research Council president Tony Perkins says he thinks Congress is wasting its time promoting embryonic stem cell research when it is nowhere close to helping any patients. He said it should look to the use of adult stem cells instead.
"Is it just me or is something wrong with that picture?" he told LifeNews.com.
"While Congress fritters away its time on science that has yielded little in the way of real treatments, the journal Cell Proliferation has published a study on adult stem cells extracted from the umbilical cords of newborns," he said.
As LifeNews.com has reported, those "adult" cells have been successfully engineered to produce insulin and could soon be used to treat diabetes patients.
"If Congress is going to spend our hard-earned money, I suggest they put it to better use and fund true progress like this," Perkins said.
ACTION: Contact your members of Congress and urge them to oppose the bill forcing people to pay for embryonic stem cell research and to vote against any attempt to override a presidential veto. You can call 202-224-3121 and connect with any legislator.